Loss of Progesterone Receptor Expression Is an Early Tumorigenesis Event Associated with Tumor Progression and Shorter Survival in Pancreatic Neuroendocrine Tumor Patients
Background Pancreatic neuroendocrine tumors (PanNETs) are the second most common pancreatic neoplasms and there is no well-elucidated biomarker to stratify their detection and prognosis. Previous studies have reported that progesterone receptor (PR) expression status was associated with poorer survi...
Main Authors: | Sung Joo Kim, Soyeon An, Jae Hoon Lee, Joo Young Kim, Ki-Byung Song, Dae Wook Hwang, Song Cheol Kim, Eunsil Yu, Seung-Mo Hong |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Pathologists & the Korean Society for Cytopathology
2017-07-01
|
Series: | Journal of Pathology and Translational Medicine |
Subjects: | |
Online Access: | http://www.jpatholtm.org/upload/pdf/jptm-2017-03-19.pdf |
Similar Items
-
Clinical and Prognostic Significances of Cytokeratin 19 and KIT Expression in Surgically Resectable Pancreatic Neuroendocrine Tumors
by: Eun-Mi Son, et al.
Published: (2015-01-01) -
Pancreatic Hemangioma Suspected of Neuroendocrine Tumor
by: Mo Ah Jeong, et al.
Published: (2020-07-01) -
Prognostic value of CT-based radiomics in grade 1–2 pancreatic neuroendocrine tumors
by: Subin Heo, et al.
Published: (2024-02-01) -
Recent Updates in the Management of Advanced Pancreatic Neuroendocrine Tumors
by: Chang Min Cho
Published: (2019-03-01) -
Treatment Options for Pancreatic Neuroendocrine Tumors
by: Amit Akirov, et al.
Published: (2019-06-01)